BMC Gastroenterology (Dec 2018)

Risk factor for steatorrhea in pediatric chronic pancreatitis patients

  • Lu Hao,
  • Teng Wang,
  • Lin He,
  • Ya-Wei Bi,
  • Di Zhang,
  • Xiang-Peng Zeng,
  • Lei Xin,
  • Jun Pan,
  • Dan Wang,
  • Jun-Tao Ji,
  • Ting-Ting Du,
  • Jin-Huan Lin,
  • Li-Sheng Wang,
  • Wen-Bin Zou,
  • Hui Chen,
  • Ting Xie,
  • Hong-Lei Guo,
  • Bai-Rong Li,
  • Zhuan Liao,
  • Zheng-Lei Xu,
  • Zhao-Shen Li,
  • Liang-Hao Hu

DOI
https://doi.org/10.1186/s12876-018-0902-z
Journal volume & issue
Vol. 18, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background Pediatric patients always suffer from chronic pancreatitis (CP), especially those with steatorrhea. This study aimed to identify the incidence of and risk factors for steatorrhea in pediatric CP. To our best knowledge, there is no pediatric study to document the natural history of steatorrhea in CP. Methods CP patients admitted to our center from January 2000 to December 2013 were enrolled. Patients were assigned to the pediatric (< 18 years old) and adult group according to their age at onset of CP. Cumulative rates of steatorrhea in both groups were calculated. Risk factors for both groups were identified, respectively. Results The median follow-up duration for the whole cohort was 7.6 years. In a total of 2153 patients, 13.5% of them were pediatrics. The mean age at the onset and the diagnosis of CP in pediatrics were 11.622 and 19.727, respectively. Steatorrhea was detected in 46 patients (46/291, 15.8%) in the pediatric group and in 447 patients (447/1862, 24.0%) in the adult group. Age at the onset of CP (hazard ratio [HR], 1.121), diabetes mellitus (DM, HR, 51.140), and severe acute pancreatitis (SAP, HR, 13.946) was identified risk factor for steatorrhea in the pediatric group. Conclusions Age at the onset of CP, DM and SAP were identified risk factors for the development of steatorrhea in pediatric CP patients. The high-risk populations were suggested to be followed up closely. They may benefit from a full adequate pancreatic exocrine replacement therapy.

Keywords